Literature DB >> 17509037

Dose-dependent acute excessive weight gain and metabolic changes in a drug-naive patient on risperidone are reversible with discontinuation: a case report.

Saddichha Sahoo, Biswaranjan Mishra, Sayeed Akhtar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17509037      PMCID： PMC2203261          DOI： 10.1111/j.1365-2125.2007.02941.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  11 in total

1.  Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone.

Authors:  B R Basson; B J Kinon; C C Taylor; K A Szymanski; J A Gilmore; G D Tollefson
Journal:  J Clin Psychiatry       Date:  2001-04       Impact factor: 4.384

2.  A meta-analysis of the efficacy of second-generation antipsychotics.

Authors:  John M Davis; Nancy Chen; Ira D Glick
Journal:  Arch Gen Psychiatry       Date:  2003-06

Review 3.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies.

Authors: 
Journal:  Lancet       Date:  2004-01-10       Impact factor: 79.321

Review 4.  Antipsychotic-induced weight gain: a comprehensive research synthesis.

Authors:  D B Allison; J L Mentore; M Heo; L P Chandler; J C Cappelleri; M C Infante; P J Weiden
Journal:  Am J Psychiatry       Date:  1999-11       Impact factor: 18.112

5.  A crossover study on lipid and weight changes associated with olanzapine and risperidone.

Authors:  Kuan-Pin Su; Po-Lun Wu; Carmine M Pariante
Journal:  Psychopharmacology (Berl)       Date:  2005-10-21       Impact factor: 4.530

6.  Metabolic effects of treatment with atypical antipsychotics.

Authors:  John M Kane; Eugene J Barrett; Daniel E Casey; Christoph U Correll; Alan J Gelenberg; Samuel Klein; John W Newcomer
Journal:  J Clin Psychiatry       Date:  2004-11       Impact factor: 4.384

7.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2000

8.  Elevated serum triglycerides with clozapine resolved with risperidone in four patients.

Authors:  P Ghaeli; R L Dufresne
Journal:  Pharmacotherapy       Date:  1999-09       Impact factor: 4.705

9.  A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia.

Authors:  John G Csernansky; Ramy Mahmoud; Ronald Brenner
Journal:  N Engl J Med       Date:  2002-01-03       Impact factor: 91.245

10.  Cutoff values for normal anthropometric variables in asian Indian adults.

Authors:  Chamukuttan Snehalatha; Vijay Viswanathan; Ambady Ramachandran
Journal:  Diabetes Care       Date:  2003-05       Impact factor: 19.112
View more
  2 in total

1.  The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions.

Authors:  C Rafaniello; M Sessa; F F Bernardi; M Pozzi; S Cheli; D Cattaneo; S Baldelli; M Molteni; R Bernardini; F Rossi; E Clementi; C Bravaccio; S Radice; A Capuano
Journal:  Pharmacogenomics J       Date:  2017-07-18       Impact factor: 3.550

2.  Reversibility of Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis.

Authors:  Helene Speyer; Casper Westergaard; Nikolai Albert; Mette Karlsen; Anne Emilie Stürup; Merete Nordentoft; Jesper Krogh
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-28       Impact factor: 5.555
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.